1. 46P Development of an allogeneic CAR-T targeting MUC1-C (MUC1, cell surface associated, C-terminal) for epithelial derived tumors. (December 2022) Authors: Oh, D.; Henry, J.; Baranda, J.C.; Dumbrava, E.E.; Cohen, E.; Eskew, J.D.; Belani, R.; McCaigue, J.; Namini, H.; Martin, C.; Murphy, A.; Ostertag, E.; Coronella, J.; Shedlock, D.; Rodriguez Rivera, I.I. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 47P Phase I study to assess the safety and efficacy of P-BCMA-ALLO1: A fully allogeneic CAR-T therapy, in patients with relapsed/refractory multiple myeloma (RRMM). (December 2022) Authors: Kocoglu, M.H.; Asch, A.; Ramakrishnan, A.; Bachier, C.; Martin, T.; Rodriguez, T.; McArthur, K.; Martin, C.; Namini, H.; Ostertag, E.; Spear, M.; Christie, E.; Belani, R.; Zhang, M.; Cranert, S.; Coronella, J.; Shedlock, D.; Costello, C. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Investigation of combined kV/MV CBCT imaging with a high‐DQE MV detector. Issue 2 (6th December 2018) Authors: Lindsay, C.; Bazalova‐Carter, M.; Wang, A.; Shedlock, D.; Wu, M.; Newson, M.; Xing, L.; Ansbacher, W.; Fahrig, R.; Star‐Lack, J. Journal: Medical physics Issue: Volume 46:Issue 2(2019) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗